DQT's mission is to develop and present work by BIPoC and Female-identifying writers; concurrently, cultivate and maintain a diverse audience who is in routine discourse with them. 

DQT envisions an American theatre wherein the population of professionally produced playwrights is as diverse as America.

NEW PLAY DEVELOPMENT - PROCESS IS OUR PRODUCT

Upcoming shows

Yerma in Vitro by Oliver Mayer, directed by Tatyana-Marie Carlo.

May 28 and 29, 2025, 7pm at Playwrights Horizons Downtown. 440 Lafayette Street, Third Floor, New York, NY 10003

Developed in DQT’s Classics in Color program, Yerma in Vitro is a modern adaptation of Lorca’s masterpiece: Yerma needs love. A custodian to rich undergrads at an elite university, she is part of an invisible underclass whose needs and desires are being silenced by fear and cruelty. But her yearning is bigger than anyone realizes. This new take on Lorca’s tale follows a childless young woman searching for love at any cost and places it in an ongoing Trumpian dystopia.

Oliver Mayer, playwright

News

DQT Congratulates Christin Eve Cato

May 10th-June 8 

Congratulations to Christin Eve Cato (Playwright, American Woman) on the premiere of her play O.K.! at Intar Theater from May 10th-June 8th. Congratulations Christin!

DQT Congratulates Rajendra Ramoon Maharaj 

Congratulations to Rajendra Ramoon Maharaj (Playwright, Classics in Color) for being selected for the 2025 HB Studio Residency this July. During this residency, Rajendra will have the opportunity to continue working on waiting, a play developed in DQT’s Classics in Color program. Also, Rajendra was selected as a finalist for the 2025 Blue Ink Playwriting Award. Congratulations, Rajendra!

DQT Congratulates Rajendra Ramoon Maharaj 

May 21st-June 1st

Congratulations to Rajendra Ramoon Maharaj  (Playwright, Classics in Color) for being selected for The New Harmony Project’s 2025 Annual Writers Residency from May 21st-June 1, 2025. Congratulations Rajendra Ramoon Maharaj! 

DQT Instagram

USFCR Verified Vendor

The dramatic question theatre Is supported in part by: